SCHEMBL24933385

SCHEMBL24933385

NC(=O)c1cc(-c2ccc(OCc3cnc(O)nc3)cc2)c(C(F)(F)F)[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
MAOB P27338 3/20 0.38
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CHEK2 O96017 1/20 0.35
HSD17B1 P14061 3/20 0.35
HSD17B2 P37059 3/20 0.35
GSTP1 P09211 1/20 0.34
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933463 0.90 HSD17B1 (0.41) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24933213 0.89 MAOB (0.36) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24933709 0.89 MAOB (0.36) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24933810 0.89 FFAR4 (0.40) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24933216 0.89 HSD17B1 (0.36) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24933508 0.88 MRGPRX4 (0.41) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL30240820 0.88 MAOB (0.39) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24933804 0.88 MAOB (0.39) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL24932994 0.88 MAOB (0.35) PARP1HDAC3HDAC4HDAC1HDAC7
SCHEMBL30240772 0.87 NPC1 (0.43) PARP1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed